Daniel K. Spiegelman, Director: Myriad Genetics MYGN Sell · Filed 23/06/02

Trade details

Type: Insider sale
Amount: $198,760.38
Shares · price: 8,638 sh · $23.01 a share
Held after: 40,493 sh
Stock: Myriad Genetics MYGN
Person: Daniel K. SpiegelmanDirector
Trade date: 23/06/02
Filed: 23/06/02
Days to filing: 0 days

Sold 17.6% of holdings

Share of holding sold: 17.6%

Myriad Genetics trades, last 26 weeks

What else happened in Myriad Genetics around then

Filed or reported within 30 days of the trade day · 23/05/03~23/07/02

Daniel K. Spiegelman's recent trades

Daniel K. SpiegelmanDirector
Planned saleKyverna Therapeutics
Planned sale
Kyverna Therapeutics
KYTX
$162.6K
17,578 sh
$162.6K
Filed 04/07
Traded 04/07
Daniel K. SpiegelmanDirector
Planned saleKyverna Therapeutics
Planned sale
Kyverna Therapeutics
KYTX
$140.4K
16,634 sh
$140.4K
Filed 03/31
Traded 03/31
Daniel K. SpiegelmanDirector
Sell10b5-1 planMyriad Genetics
Sell10b5-1 plan
Myriad Genetics
MYGN
$83.5K
3,788 sh
$83.5K
Filed 24/06/04
Traded 24/06/03
Daniel K. SpiegelmanDirector
Sell10b5-1 planMyriad Genetics
Sell10b5-1 plan
Myriad Genetics
MYGN
$83.5K
3,788 sh
$83.5K
Filed 24/06/04
Traded 24/06/04